SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-636582
Filing Date
2016-06-29
Accepted
2016-06-29 16:16:56
Documents
1
Group Members
MERCK & CO., INC.MERCK SHARP & DOHME CORP.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO.2 d221689dsc13da.htm SC 13D/A 125388
  Complete submission text file 0001193125-16-636582.txt   126913
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Subject) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88842 | Film No.: 161739011
SIC: 8071 Services-Medical Laboratories

Mailing Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889
Business Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889 908-740-4000
Merck Global Health Innovation Fund, LLC (Filed by) CIK: 0001547132 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A